日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease

家族性帕金森病患者 iPSC 衍生神经细胞线粒体缺陷的药物治疗

Oliver Cooper, Hyemyung Seo, Shaida Andrabi, Cristina Guardia-Laguarta, John Graziotto, Maria Sundberg, Jesse R McLean, Luis Carrillo-Reid, Zhong Xie, Teresia Osborn, Gunnar Hargus, Michela Deleidi, Tristan Lawson, Helle Bogetofte, Eduardo Perez-Torres, Lorraine Clark, Carol Moskowitz, Joseph Mazzul

Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies

一项针对复发或难治性淋巴瘤患者的II-I-II期临床研究,比较了两种不同剂量和给药方案的普拉曲沙(一种还原型叶酸载体的高亲和力底物),结果显示其对T细胞恶性肿瘤具有显著疗效。

O'Connor, Owen A; Horwitz, Steven; Hamlin, Paul; Portlock, Carol; Moskowitz, Craig H; Sarasohn, Debra; Neylon, Ellen; Mastrella, Jill; Hamelers, Rachel; Macgregor-Cortelli, Barbara; Patterson, Molly; Seshan, Venkatraman E; Sirotnak, Frank; Fleisher, Martin; Mould, Diane R; Saunders, Mike; Zelenetz, Andrew D

Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma

每周一次硼替佐米治疗套细胞淋巴瘤和滤泡性淋巴瘤的 II 期研究

Gerecitano, John; Portlock, Carol; Moskowitz, Craig; Hamlin, Paul; Straus, David; Zelenetz, Andrew D; Zhang, Zhigang; Dumitrescu, Otilia; Sarasohn, Debra; Lin, Dorothy; Pappanicholaou, Jennifer; Cortelli, Barbara M; Neylon, Ellen; Hamelers, Rachel; Wright, John; O'Connor, Owen A